Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|May 5, 2018
Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalitiesThomas Shum, Robert L Kruse, Cliona M Rooney
Radiographics : a Review Publication of the Radiological Society of North America, Inc|August 12, 2022
Imaging Findings of Thoracic Lymphatic AbnormalitiesJingshuo Derek Sun, Thomas Shum, Fardad Behzadi, et al.
Analytical and Bioanalytical Chemistry|November 12, 2010
Enhanced detection of olefins using ambient ionization mass spectrometry: Ag+ adducts of biologically relevant alkenesAyanna U Jackson, Thomas Shum, Ewa Sokol, et al.
International Journal of Molecular Sciences|November 14, 2023
Constitutive Interleukin-7 Cytokine Signaling Enhances the Persistence of Epstein-Barr Virus-Specific T-CellsSandhya Sharma, Tim Sauer, Bilal A Omer, et al.
Molecular Therapy. Methods & Clinical Development|October 12, 2017
In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV ImmunotherapyRobert L Kruse, Thomas Shum, Xavier Legras, et al.
Human Gene Therapy|March 12, 2020
Adult and Cord Blood-Derived High-Affinity gB-CAR-T Cells Effectively React Against Human Cytomegalovirus InfectionsHenning Olbrich, Sebastian J Theobald, Constanze Slabik, et al.
Gastrointestinal Endoscopy|July 1, 2021
Endoscopic-mediated, biliary hydrodynamic injection mediating clinically relevant levels of gene delivery in pig liverRobert L Kruse, Yuting Huang, Thomas Shum, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2017
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1Haruko Tashiro, Tim Sauer, Thomas Shum, et al.
Cytotherapy|April 11, 2018
HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric miceRobert L Kruse, Thomas Shum, Haruko Tashiro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2017
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T CellsMichael Schmueck-Henneresse, Bilal Omer, Thomas Shum, et al.
Pageof 2